All News #Library
Others
twoXAR Presents Preclinical Data Demonstrating Positive Safety and Tolerability
13 Nov 2020 //
PRNEWSWIRE
twoXAR Pharma Presents Positive Preclinical Safety and Efficacy Data TXR-311
22 Jun 2020 //
PRNEWSWIRE
1ST Biotherapeutics and twoXAR Advance Three Novel Glioblastoma
25 Feb 2020 //
PR NEWSWIRE

Market Place
Sourcing Support